{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T13:51:01Z","timestamp":1725889861808},"reference-count":9,"publisher":"Informa UK Limited","issue":"sup1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Pressure"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/080370500439191","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:29:42Z","timestamp":1027686582000},"page":"27-30","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups"],"prefix":"10.1080","volume":"9","author":[{"given":"PETER","family":"TRENKWALDER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"112A","volume":"10","author":"McGregor GA","year":"1997","journal-title":"The efficacy of can-desartan, an angiotensin II type I receptor antagonist alone or in combination with amlodipine or in combination with amlodipine and hydrochlorothiazide in patients with mod-erate-to-severe essential hypertension. Am J Hypertens"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1080\/080370598437385"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(94)00245-7"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)88958-3"},{"issue":"5","key":"CIT0005","first-page":"117","volume":"3","author":"Kawabata M","year":"1994","journal-title":"Blood Press"},{"issue":"63","key":"CIT0006","first-page":"185","volume":"52","author":"Buter H","year":"1997","journal-title":"Renal haemo-dynamic effects of the angiotensin II receptor antagonist candesartan cilexetil in patients with impaired and normal renal function. Kidney Int"},{"key":"CIT0007","first-page":"3255","volume":"265","author":"SHEP Cooperative Research","year":"1991","journal-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA"},{"key":"CIT0008","first-page":"1281","volume":"338","author":"Dahl\u00f6f B","year":"1991","journal-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hyperten-sion). Lancet"},{"key":"CIT0009","first-page":"272","volume":"15","author":"Bell TP","year":"1999","journal-title":"Candesartan Cilexetil Study Investigators. Am J Cardiol"}],"container-title":["Blood Pressure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/080370500439191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T11:11:16Z","timestamp":1492686676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/080370500439191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":9,"journal-issue":{"issue":"sup1","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/080370500439191"],"URL":"https:\/\/doi.org\/10.1080\/080370500439191","relation":{},"ISSN":["0803-7051","1651-1999"],"issn-type":[{"value":"0803-7051","type":"print"},{"value":"1651-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}